Topiramate and temporal lobe epilepsy: An open-label study

Epileptic Disorders

Volumn 14, Issue 2, 2012, Pages 163-166

  Labate, Angelo ^a   Siniscalchi, Antonio ^b   Mumoli, Laura ^a   Aguglia, Umberto ^a   Quattrone, Aldo ^a   Gambardella, Antonio ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Annunziata Hospital   (Italy)

^c INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Antiepileptic drugs; Temporal lobe epilepsy; Topiramate

Indexed keywords

TOPIRAMATE;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; MALE; MONOTHERAPY; OPEN STUDY; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; TEMPORAL LOBE EPILEPSY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGE OF ONSET; AGED; ANTICONVULSANTS; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; FEMALE; FEVER; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEIZURES;

EID: 84864562433     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2012.0497     Document Type: Article

References (19)

1. Aguglia U, Gambardella A, Le Piane E, et al. Mild non-lesional temporal lobe epilepsy. a common unrecognized disorder with onset in adulthood. Can J Neurol Sci 1998; 25: 282-6.
2. Andreou AP, Goadsby PJ. Topiramate in the treatment of migraine: a kainite glutamate receptor antagonist within the trigeminothalamic pathway. Cephalgia 2011; 31: 1343-58.
3. Artinian J, Peret A, Marti G, Epsztein J, Crépel V. Synaptic kainite receptors in interplay with INA shift the sparse firing of dentate granule cells to a sustained rhythmic mode in temporal lobe epilepsy. J Neurosci 2011; 31: 10811-8.
4. Bergey GK. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs. Epilepsia 2005; 46: 161-8.
5. Commission on Classification Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.
6. El Yaman SH, Mroueh SM, Sinno DD, Mikati MA. Long-term patterns of weight changes during topiramate therapy: an observational study. Neurology 2007; 69: 310-1.
7. Gambardella A, Pucci F, La Piane E, et al. Usefulness of latero-orbital electrodes in detecting interictal epileptiform activity-a study of 60 patients with complex partial seizures. Electroencephalogr Clin Neurophysiol 1998; 107: 174-6.
8. Gambardella A, Manna I, Labate A, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003; 60: 560-3.
9. Giannakodimos ST, Georgiadis G, Tsounis ST, et al. Add-on topiramate in the treatment of refractory partial-onset epilepsy: clinical experience of outpatient epilepsy clinics from 11 general hospitals. Seizure 2005; 14: 396-402.
10. Glauser TA, Levisohn PM, Ritter F, Sachdeo RC. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group. Epilepsia 2000; 41: S86-90.
11. Herrero AI, Del Olmo N, González-Escalada JR, Solís JM. Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance. Neuropharmacology 2002; 42: 210-20.
12. Jette N, Hemming K, Hutton JL, Marson AG. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2008; 3: CD001417.
13. Kaminski RM, Banerjee M, Rogawski MA. Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology 2004; 46: 1097-104.
14. Labate A, Ventura P, Gambardella A, et al. MRI evidence of mesial temporal sclerosis in sporadic "benign" temporal lobe epilepsy. Neurology 2006; 66: 562-5.
15. Labate A, Cerasa A, Gambardella A, Aguglia U, Quattrone A. Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study. Neurology 2008; 71: 1094-101.
16. Labate A, Gambardella A, Andermann E, et al. Benign mesial temporal lobe epilepsy. Nat Rev Neurol 2011; 7: 237-40.
17. Park HJ, Kim HJ, Park HJ, et al. Protective effect of topiramate on kainic acid-induced cell death in mice hippocampus. Epilepsia 2008; 49: 163-7.
18. Sachdeo RC, Reife RA, Lim P, Pledger G. Topiramate monotherapy for partial onset seizures. Epilepsia 1997; 38: 294-300.
19. Siniscalchi A, Gallelli L, De Sarro GB. Use of antiepileptic drugs for hyperkineticmovement disorders. Curr Neuropharmacol 2010; 8: 359-66.